• Year-on-year, leading companies
    trust GBI Research's clinical & competitive research
Who We Help
Medical Device Suppliers and Manufacturers
You are here:
Who we help >
Medical Device Suppliers and Manufacturers

Medical Device Suppliers and Manufacturers

As competitive dynamics change and consolidation gathers pace, our market and issue analysis reports support executives and analysts active in or supplying services to the global medical equipment industry:

  • MedTech, medical devices and diagnostics manufacturers

  • Professional service providers

  • Investment community

  • Academic institutions

  • Supply chain companies

  • Technology providers

Small, niche technology companies proliferate but are coming to the attention of bigger players seeking to expand their product range or gain access to innovation.

Expanding national markets have fast-developing MedTech sectors, encouraging the growth of domestic industry and attracting the attention of MNCs looking for insights to help them face new challenges.

Analyst Views

28 Nov 16
Repurposing Type 2 Diabetes Mellitus Drugs for Alzheimer’s ....
In this Analyst View, Fiona Chisholm, Analyst for GBI Research, discusses the potential f.....
Read post
21 Nov 16
Urological Cancer Treatment Landscape to be Transformed by ....
In this Analyst View, Adam Bradbury, Associate Analyst for GBI Research, discuses current.....
Read post

White Papers

22 Nov 16
An Exploration of Novel and Repositioned Calcium Transport ....
This whitepaper discusses the increasing interest in using repositioned calcium transport....
Read post
14 Nov 16
The Emerging Field of Cannabinoid-Based Products....
This white paper discusses the current commercial landscape for cannabinoid-based product....
Read post

Press Releases

15 Feb 17
Immunology attracting high level of investment as companies....
With a total of 2,145 products currently in development, the immunology market is experie.....
Read post
14 Feb 17
Roche to gain most as Biogen remains leader in neurodegener....
Roche will be the biggest mover in the neurodegenerative drugs space over the next five y.....
Read post